檢索結果 - Michael Teufel

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma

    Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma 由 Michael Teufel, Henrik Seidel, Karl Köchert, Gerold Meinhardt, Richard S. Finn, Josep M. Llovet, Jordi Bruix

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.

    Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. 由 Utz Fischer, Sylvie C. Meyer, Michael Teufel, Cecile Dupin de Saint Cyr - Heckel, Reinhard Lührmann, G Rautmann

    出版 1994
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma

    Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma 由 Maria Kissel, Sandra Berndt, Lukas Fiebig, Simon Kling, Qunsheng Ji, Qingyang Gu, Tina Lang, Frank‐Thorsten Hafner, Michael Teufel, Dieter Zopf

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors

    Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors 由 Changhoon Yoo, Ángela Lamarca, Hye Jin Choi, Arndt Vogel, Michael J. Pishvaian, Lipika Goyal, Makoto Ueno, Angela Märten, Michael Teufel, Lijiang Geng, Chigusa Morizane

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series

    Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series 由 Noboru Yamamoto, Anthony W. Tolcher, Navid Hafez, Iwona Ługowska, Rodryg Ramlau, Teresa Macarulla, Junxian Geng, Jian Li, Michael Teufel, Angela Märten, Patricia LoRusso

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study

    The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study 由 Patricia LoRusso, Noboru Yamamoto, Manish R. Patel, Scott A. Laurie, Todd M. Bauer, Junxian Geng, Teffany Davenport, Michael Teufel, Jian Li, Mehdi Lahmar, Mrinal M. Gounder

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

    Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospecti... 由 Josep Tabernero, Heinz‐Josef Lenz, Salvatore Siena, Alberto Sobrero, Alfredo Falcone, Marc Ychou, Yves Humblet, Olivier Bouché, Laurent Mineur, Carlo Barone, Antoine Adenis, Takayuki Yoshino, Richard M. Goldberg, Daniel J. Sargent, Thierry André, Dirk Laurent, Michael Teufel, Michael Jeffers, Axel Grothey, Eric Van Cutsem

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with <i>RAS</i>-Mutated Hepatocellular Carcinoma

    Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with <i>RAS</i>-Mutated Hepatocellular Carcinoma 由 Ho Yeong Lim, Philippe Merle, Karl Weiss, Thomas Yau, Paul J. Ross, Vincenzo Mazzaferro, Jean‐Frédéric Blanc, Yuk Ting, Chia Jui Yen, Judit Kocsis, Su Pin Choo, Wattana Sukeepaisarnjaroen, René Gerolami, Jean‐François Dufour, Edward Gane, Baek‐Yeol Ryoo, Markus Peck‐Radosavljevic, Thông Dao, Winnie Yeo, Wisut Lamlertthon, Satawat Thongsawat, Michael Teufel, Katrin Roth, Diego Reis, Barrett H. Childs, Heiko Krissel, Josep M. Llovet

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: